Showing results (151-160 of 352) with videos related to
Sort By:
Pageof 36
Basic & Clinical Pharmacology & Toxicology|October 13, 2016
Lipid-soluble Cigarette Smoke Particles Induced Vascular Endothelin Type A Receptor Up-Regulation through Activation of ERK1/2 Signal PathwaysYaping Zhang, Wei Zhang, Lars Edvinsson, et al.European Journal of Pharmacology|January 22, 2014
Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteriesYaping Zhang, Wei Zhang, Lars Edvinsson, et al.Frontiers in Physiology|January 31, 2022
Neuropeptides and the Nodes of Ranvier in Cranial HeadachesJacob C A Edvinsson, Kristian A Haanes, Lars EdvinssonPharmacology|September 5, 2019
The Presence of Calcitonin Gene-Related Peptide and Its Receptors in Rat, Pig and Human Brain: Species Differences in Calcitonin Gene-Related Peptide PharmacologyKarin Warfvinge, Lars Edvinsson, Darryl S Pickering, et al.European Journal of Pharmacology|May 5, 2007
Effect of two novel CGRP-binding compounds in a closed cranial window rat modelLouise Juhl, Lars Edvinsson, Jes Olesen, et al.Translational Stroke Research|January 23, 2014
Plasticity of cerebrovascular smooth muscle cells after subarachnoid hemorrhageLars Edvinsson, Stine Schmidt Larsen, Aida Maddahi, et al.Annals of Clinical and Translational Neurology|June 18, 2024
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disordersNazia Karsan, Lars Edvinsson, Laszlo Vecsei, et al.The Journal of Headache and Pain|October 30, 2015
Experimental inflammation following dural application of complete Freund's adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passageCornelia Lundblad, Kristian A Haanes, Gustaf Grände, et al.British Journal of Pharmacology|August 19, 2021
Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene-related peptide family of peptidesLars Edvinsson, Jacob C A Edvinsson, Kristian A HaanesThe Journal of Allergy and Clinical Immunology|February 22, 2017
Substance P represents a novel first-line defense mechanism in the noseOlivia Larsson, Lotta Tengroth, Yuan Xu, et al.Pageof 36